Steve Johnston
About Steve Johnston
Steve Johnston serves as the Head of Technologies at the Broad Institute of MIT and Harvard, where he focuses on scaling technologies for therapeutic applications. He has extensive experience in drug discovery, having held various leadership roles at the Broad Institute and Schering-Plough Corporation.
Current Role at Broad Institute
Steve Johnston currently serves as the Head of Technologies at the Broad Institute of MIT and Harvard. He has held this position since 2023. In this role, he focuses on scaling differentiating technologies in collaboration with originating labs for therapeutic applications. Johnston ensures that the technologies align strategically with the drug discovery portfolio at the Center for the Development of Therapeutics.
Previous Experience at Broad Institute
Prior to his current role, Johnston worked at the Broad Institute of MIT and Harvard from 2018 to 2023. He served as the Associate Director of CDoT Operations for three years, followed by a two-year tenure as Director of Discovery Solutions. His work during this time contributed to advancements in drug discovery and operational efficiency within the institute.
Educational Background
Steve Johnston has a strong educational background in the sciences and business. He earned a Bachelor of Science in Chemistry from Davidson College, where he studied from 1996 to 2000. He then pursued a PhD in Analytical Chemistry at the University of North Carolina at Chapel Hill from 2000 to 2005. Later, he completed a Master of Business Administration at MIT Sloan School of Management from 2020 to 2022.
Professional Experience Prior to Broad Institute
Before joining the Broad Institute, Johnston worked as a Senior Scientist at Schering-Plough Corporation for one year in 2006-2007. His experience in this role contributed to his expertise in strategic operations and management within the drug discovery field.
Expertise in Drug Discovery
Steve Johnston has a proven track record in strategic operations and management within drug discovery. His focus on ensuring the alignment of technologies with therapeutic applications has positioned him as a key contributor in the field. His extensive experience across various roles has equipped him with the skills necessary to drive innovation and efficiency in drug development.